A fully synthetic human Fab antibody library based on fixed VH/VL framework pairings with favorable biophysical properties

References

• Carter PJ. Potent antibody therapeutics by design. Nat Rev Immunol 2006; 6:343 - 57; http://dx.doi.org/10.1038/nri1837; PMID: 16622479
   PubMed Web of Science ®Google Scholar
• Traggiai E, Becker S, Subbarao K, Kolesnikova L, Uematsu Y, Gismondo MR, et al. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat Med 2004; 10:871 - 5; http://dx.doi.org/10.1038/nm1080; PMID: 15247913
   PubMed Web of Science ®Google Scholar
• Olsson L, Kaplan HS. Human-human hybridomas producing monoclonal antibodies of predefined antigenic specificity. Proc Natl Acad Sci U S A 1980; 77:5429 - 31; http://dx.doi.org/10.1073/pnas.77.9.5429; PMID: 6159646
   PubMed Web of Science ®Google Scholar
• Meijer PJ, Andersen PS, Haahr Hansen M, Steinaa L, Jensen A, Lantto J, et al. Isolation of human antibody repertoires with preservation of the natural heavy and light chain pairing. J Mol Biol 2006; 358:764 - 72; http://dx.doi.org/10.1016/j.jmb.2006.02.040; PMID: 16563430
   PubMed Web of Science ®Google Scholar
• Tiller T, Meffre E, Yurasov S, Tsuiji M, Nussenzweig MC, Wardemann H. Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. J Immunol Methods 2008; 329:112 - 24; http://dx.doi.org/10.1016/j.jim.2007.09.017; PMID: 17996249
   PubMed Web of Science ®Google Scholar
• Tiller T. Single B cell antibody technologies. N Biotechnol 2011; 28:453 - 7; http://dx.doi.org/10.1016/j.nbt.2011.03.014; PMID: 21473940
   PubMed Web of Science ®Google Scholar
• Köhler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256:495 - 7; http://dx.doi.org/10.1038/256495a0; PMID: 1172191
   PubMed Web of Science ®Google Scholar
• Lonberg N. Human monoclonal antibodies from transgenic mice. Handb Exp Pharmacol 2008; 69 - 97; http://dx.doi.org/10.1007/978-3-540-73259-4_4; PMID: 18071942
   PubMedGoogle Scholar
• Hanes J, Plückthun A. In vitro selection and evolution of functional proteins by using ribosome display. Proc Natl Acad Sci U S A 1997; 94:4937 - 42; http://dx.doi.org/10.1073/pnas.94.10.4937; PMID: 9144168
   PubMed Web of Science ®Google Scholar
• He M, Taussig MJ. Antibody-ribosome-mRNA (ARM) complexes as efficient selection particles for in vitro display and evolution of antibody combining sites. Nucleic Acids Res 1997; 25:5132 - 4; http://dx.doi.org/10.1093/nar/25.24.5132; PMID: 9396828
   PubMed Web of Science ®Google Scholar
• Boder ET, Wittrup KD. Yeast surface display for screening combinatorial polypeptide libraries. Nat Biotechnol 1997; 15:553 - 7; http://dx.doi.org/10.1038/nbt0697-553; PMID: 9181578
   PubMed Web of Science ®Google Scholar
• McCafferty J, Griffiths AD, Winter G, Chiswell DJ. Phage antibodies: filamentous phage displaying antibody variable domains. Nature 1990; 348:552 - 4; http://dx.doi.org/10.1038/348552a0; PMID: 2247164
   PubMed Web of Science ®Google Scholar
• Smith GP. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 1985; 228:1315 - 7; http://dx.doi.org/10.1126/science.4001944; PMID: 4001944
   PubMed Web of Science ®Google Scholar
• Winter G, Griffiths AD, Hawkins RE, Hoogenboom HR. Making antibodies by phage display technology. Annu Rev Immunol 1994; 12:433 - 55; http://dx.doi.org/10.1146/annurev.iy.12.040194.002245; PMID: 8011287
   PubMed Web of Science ®Google Scholar
• Marks JD, Hoogenboom HR, Bonnert TP, McCafferty J, Griffiths AD, Winter G. By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J Mol Biol 1991; 222:581 - 97; http://dx.doi.org/10.1016/0022-2836(91)90498-U; PMID: 1748994
   PubMed Web of Science ®Google Scholar
• Vaughan TJ, Williams AJ, Pritchard K, Osbourn JK, Pope AR, Earnshaw JC, et al. Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library. Nat Biotechnol 1996; 14:309 - 14; http://dx.doi.org/10.1038/nbt0396-309; PMID: 9630891
   PubMed Web of Science ®Google Scholar
• Huse WD, Sastry L, Iverson SA, Kang AS, Alting-Mees M, Burton DR, et al. Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda. Science 1989; 246:1275 - 81; http://dx.doi.org/10.1126/science.2531466; PMID: 2531466
   PubMed Web of Science ®Google Scholar
• Hoet RM, Cohen EH, Kent RB, Rookey K, Schoonbroodt S, Hogan S, et al. Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity-determining-region diversity. Nat Biotechnol 2005; 23:344 - 8; http://dx.doi.org/10.1038/nbt1067; PMID: 15723048
   PubMed Web of Science ®Google Scholar
• Knappik A, Ge L, Honegger A, Pack P, Fischer M, Wellnhofer G, et al. Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides. J Mol Biol 2000; 296:57 - 86; http://dx.doi.org/10.1006/jmbi.1999.3444; PMID: 10656818
   PubMed Web of Science ®Google Scholar
• Prassler J, Thiel S, Pracht C, Polzer A, Peters S, Bauer M, et al. HuCAL PLATINUM, a synthetic Fab library optimized for sequence diversity and superior performance in mammalian expression systems. J Mol Biol 2011; 413:261 - 78; http://dx.doi.org/10.1016/j.jmb.2011.08.012; PMID: 21856311
   PubMed Web of Science ®Google Scholar
• Rothe C, Urlinger S, Löhning C, Prassler J, Stark Y, Jäger U, et al. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies. J Mol Biol 2008; 376:1182 - 200; http://dx.doi.org/10.1016/j.jmb.2007.12.018; PMID: 18191144
   PubMed Web of Science ®Google Scholar
• Ponsel D, Neugebauer J, Ladetzki-Baehs K, Tissot K. High affinity, developability and functional size: the holy grail of combinatorial antibody library generation. Molecules 2011; 16:3675 - 700; http://dx.doi.org/10.3390/molecules16053675; PMID: 21540796
   PubMed Web of Science ®Google Scholar
• Hoogenboom HR. Selecting and screening recombinant antibody libraries. Nat Biotechnol 2005; 23:1105 - 16; http://dx.doi.org/10.1038/nbt1126; PMID: 16151404
   PubMed Web of Science ®Google Scholar
• Hudson PJ. Recombinant antibody fragments. Curr Opin Biotechnol 1998; 9:395 - 402; http://dx.doi.org/10.1016/S0958-1669(98)80014-1; PMID: 9720265
   PubMed Web of Science ®Google Scholar
• Söderlind E, Strandberg L, Jirholt P, Kobayashi N, Alexeiva V, Aberg AM, et al. Recombining germline-derived CDR sequences for creating diverse single-framework antibody libraries. Nat Biotechnol 2000; 18:852 - 6; http://dx.doi.org/10.1038/78458; PMID: 10932154
   PubMed Web of Science ®Google Scholar
• Jenkins N, Murphy L, Tyther R. Post-translational modifications of recombinant proteins: significance for biopharmaceuticals. Mol Biotechnol 2008; 39:113 - 8; http://dx.doi.org/10.1007/s12033-008-9049-4; PMID: 18327554
   PubMed Web of Science ®Google Scholar
• Raab D, Graf M, Notka F, Schödl T, Wagner R. The GeneOptimizer Algorithm: using a sliding window approach to cope with the vast sequence space in multiparameter DNA sequence optimization. Syst Synth Biol 2010; 4:215 - 25; http://dx.doi.org/10.1007/s11693-010-9062-3; PMID: 21189842
   PubMedGoogle Scholar
• Virnekäs B, Ge L, Plückthun A, Schneider KC, Wellnhofer G, Moroney SE. Trinucleotide phosphoramidites: ideal reagents for the synthesis of mixed oligonucleotides for random mutagenesis. Nucleic Acids Res 1994; 22:5600 - 7; http://dx.doi.org/10.1093/nar/22.25.5600; PMID: 7838712
   PubMed Web of Science ®Google Scholar
• Van den Brulle J, Fischer M, Langmann T, Horn G, Waldmann T, Arnold S, et al. A novel solid phase technology for high-throughput gene synthesis. Biotechniques 2008; 45:340 - 3; http://dx.doi.org/10.2144/000112953; PMID: 18778261
   PubMed Web of Science ®Google Scholar
• Mietzner B, Tsuiji M, Scheid J, Velinzon K, Tiller T, Abraham K, et al. Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursors. Proc Natl Acad Sci U S A 2008; 105:9727 - 32; http://dx.doi.org/10.1073/pnas.0803644105; PMID: 18621685
   PubMed Web of Science ®Google Scholar
• Tiller T, Tsuiji M, Yurasov S, Velinzon K, Nussenzweig MC, Wardemann H. Autoreactivity in human IgG+ memory B cells. Immunity 2007; 26:205 - 13; http://dx.doi.org/10.1016/j.immuni.2007.01.009; PMID: 17306569
   PubMed Web of Science ®Google Scholar
• Tsuiji M, Yurasov S, Velinzon K, Thomas S, Nussenzweig MC, Wardemann H. A checkpoint for autoreactivity in human IgM+ memory B cell development. J Exp Med 2006; 203:393 - 400; http://dx.doi.org/10.1084/jem.20052033; PMID: 16446381
   PubMed Web of Science ®Google Scholar
• Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC. Predominant autoantibody production by early human B cell precursors. Science 2003; 301:1374 - 7; http://dx.doi.org/10.1126/science.1086907; PMID: 12920303
   PubMed Web of Science ®Google Scholar
• Yurasov S, Hammersen J, Tiller T, Tsuiji M, Wardemann H. B-cell tolerance checkpoints in healthy humans and patients with systemic lupus erythematosus. Ann N.Y. Acad.Sci 2005; 1062:165 - 74; http://dx.doi.org/10.1196/annals.1358.019
   PubMed Web of Science ®Google Scholar
• Yurasov S, Tiller T, Tsuiji M, Velinzon K, Pascual V, Wardemann H, et al. Persistent expression of autoantibodies in SLE patients in remission. J Exp Med 2006; 203:2255 - 61; http://dx.doi.org/10.1084/jem.20061446; PMID: 16966430
   PubMed Web of Science ®Google Scholar
• Brezinschek HP, Foster SJ, Brezinschek RI, Dörner T, Domiati-Saad R, Lipsky PE. Analysis of the human VH gene repertoire. Differential effects of selection and somatic hypermutation on human peripheral CD5(+)/IgM+ and CD5(-)/IgM+ B cells. J Clin Invest 1997; 99:2488 - 501; http://dx.doi.org/10.1172/JCI119433; PMID: 9153293
   PubMed Web of Science ®Google Scholar
• Demaison C, David D, Letourneur F, Thèze J, Saragosti S, Zouali M. Analysis of human VH gene repertoire expression in peripheral CD19+ B cells. Immunogenetics 1995; 42:342 - 52; http://dx.doi.org/10.1007/BF00179395; PMID: 7590967
   PubMed Web of Science ®Google Scholar
• Foster SJ, Brezinschek HP, Brezinschek RI, Lipsky PE. Molecular mechanisms and selective influences that shape the kappa gene repertoire of IgM+ B cells. J Clin Invest 1997; 99:1614 - 27; http://dx.doi.org/10.1172/JCI119324; PMID: 9120005
   PubMed Web of Science ®Google Scholar
• de Wildt RM, Hoet RM, van Venrooij WJ, Tomlinson IM, Winter G. Analysis of heavy and light chain pairings indicates that receptor editing shapes the human antibody repertoire. J Mol Biol 1999; 285:895 - 901; http://dx.doi.org/10.1006/jmbi.1998.2396; PMID: 9887257
   PubMed Web of Science ®Google Scholar
• Chothia C, Lesk AM, Gherardi E, Tomlinson IM, Walter G, Marks JD, et al. Structural repertoire of the human VH segments. J Mol Biol 1992; 227:799 - 817; http://dx.doi.org/10.1016/0022-2836(92)90224-8; PMID: 1404389
   PubMed Web of Science ®Google Scholar
• Lloyd C, Lowe D, Edwards B, Welsh F, Dilks T, Hardman C, et al. Modelling the human immune response: performance of a 1011 human antibody repertoire against a broad panel of therapeutically relevant antigens. Protein Eng Des Sel 2009; 22:159 - 68; http://dx.doi.org/10.1093/protein/gzn058; PMID: 18974080
   PubMed Web of Science ®Google Scholar
• Bhat NM, Bieber MM, Stevenson FK, Teng NN. Rapid cytotoxicity of human B lymphocytes induced by VH4-34 (VH4.21) gene-encoded monoclonal antibodies. Clin Exp Immunol 1996; 105:183 - 90; http://dx.doi.org/10.1046/j.1365-2249.1996.d01-733.x; PMID: 8697629
   PubMed Web of Science ®Google Scholar
• Glanville J, Zhai W, Berka J, Telman D, Huerta G, Mehta GR, et al. Precise determination of the diversity of a combinatorial antibody library gives insight into the human immunoglobulin repertoire. Proc Natl Acad Sci U S A 2009; 106:20216 - 21; http://dx.doi.org/10.1073/pnas.0909775106; PMID: 19875695
   PubMed Web of Science ®Google Scholar
• Tomlinson IM, Cox JP, Gherardi E, Lesk AM, Chothia C. The structural repertoire of the human V kappa domain. EMBO J 1995; 14:4628 - 38; PMID: 7556106
   PubMed Web of Science ®Google Scholar
• Williams SC, Frippiat JP, Tomlinson IM, Ignatovich O, Lefranc MP, Winter G. Sequence and evolution of the human germline V lambda repertoire. J Mol Biol 1996; 264:220 - 32; http://dx.doi.org/10.1006/jmbi.1996.0636; PMID: 8951372
   PubMed Web of Science ®Google Scholar
• Dunn-Walters D, Boursier L, Spencer J. Effect of somatic hypermutation on potential N-glycosylation sites in human immunoglobulin heavy chain variable regions. Mol Immunol 2000; 37:107 - 13; http://dx.doi.org/10.1016/S0161-5890(00)00038-9; PMID: 10865109
   PubMed Web of Science ®Google Scholar
• Carter P, Presta L, Gorman CM, Ridgway JB, Henner D, Wong WL, et al. Humanization of an anti-p185HER2 antibody for human cancer therapy. Proc Natl Acad Sci U S A 1992; 89:4285 - 9; http://dx.doi.org/10.1073/pnas.89.10.4285; PMID: 1350088
   PubMed Web of Science ®Google Scholar
• Ewert S, Huber T, Honegger A, Plückthun A. Biophysical properties of human antibody variable domains. J Mol Biol 2003; 325:531 - 53; http://dx.doi.org/10.1016/S0022-2836(02)01237-8; PMID: 12498801
   PubMed Web of Science ®Google Scholar
• Steidl S, Ratsch O, Brocks B, Dürr M, Thomassen-Wolf E. In vitro affinity maturation of human GM-CSF antibodies by targeted CDR-diversification. Mol Immunol 2008; 46:135 - 44; http://dx.doi.org/10.1016/j.molimm.2008.07.013; PMID: 18722015
   PubMed Web of Science ®Google Scholar
• Cummings MD, Farnum MA, Nelen MI. Universal screening methods and applications of ThermoFluor. J Biomol Screen 2006; 11:854 - 63; http://dx.doi.org/10.1177/1087057106292746; PMID: 16943390
   PubMed Web of Science ®Google Scholar
• Ericsson UB, Hallberg BM, Detitta GT, Dekker N, Nordlund P. Thermofluor-based high-throughput stability optimization of proteins for structural studies. Anal Biochem 2006; 357:289 - 98; http://dx.doi.org/10.1016/j.ab.2006.07.027; PMID: 16962548
   PubMed Web of Science ®Google Scholar
• He F, Hogan S, Latypov RF, Narhi LO, Razinkov VI. High throughput thermostability screening of monoclonal antibody formulations. J Pharm Sci 2010; 99:1707 - 20; PMID: 19780136
   PubMed Web of Science ®Google Scholar
• Zemlin M, Klinger M, Link J, Zemlin C, Bauer K, Engler JA, et al. Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures. J Mol Biol 2003; 334:733 - 49; http://dx.doi.org/10.1016/j.jmb.2003.10.007; PMID: 14636599
   PubMed Web of Science ®Google Scholar
• Krebs B, Rauchenberger R, Reiffert S, Rothe C, Tesar M, Thomassen E, et al. High-throughput generation and engineering of recombinant human antibodies. J Immunol Methods 2001; 254:67 - 84; http://dx.doi.org/10.1016/S0022-1759(01)00398-2; PMID: 11406154
   PubMed Web of Science ®Google Scholar
• Rauchenberger R, Borges E, Thomassen-Wolf E, Rom E, Adar R, Yaniv Y, et al. Human combinatorial Fab library yielding specific and functional antibodies against the human fibroblast growth factor receptor 3. J Biol Chem 2003; 278:38194 - 205; http://dx.doi.org/10.1074/jbc.M303164200; PMID: 12842902
   PubMed Web of Science ®Google Scholar
• McGee P. Building better antibody therapeutics. Drug Discovery & Development 2007; 10:26 - 8
   Google Scholar
• Jayaram N, Bhowmick P, Martin AC. Germline VH/VL pairing in antibodies. Protein Eng Des Sel 2012; 25:523 - 9; http://dx.doi.org/10.1093/protein/gzs043; PMID: 22802295
   PubMed Web of Science ®Google Scholar
• Schaefer JV, Plückthun A. Transfer of engineered biophysical properties between different antibody formats and expression systems. Protein Eng Des Sel 2012; 25:485 - 506; http://dx.doi.org/10.1093/protein/gzs039; PMID: 22763265
   PubMed Web of Science ®Google Scholar
• Ejima D, Tsumoto K, Fukada H, Yumioka R, Nagase K, Arakawa T, et al. Effects of acid exposure on the conformation, stability, and aggregation of monoclonal antibodies. Proteins 2007; 66:954 - 62; http://dx.doi.org/10.1002/prot.21243; PMID: 17154421
   PubMed Web of Science ®Google Scholar
• Low D, O’Leary R, Pujar NS. Future of antibody purification. J Chromatogr B Analyt Technol Biomed Life Sci 2007; 848:48 - 63; http://dx.doi.org/10.1016/j.jchromb.2006.10.033; PMID: 17134947
   PubMed Web of Science ®Google Scholar
• Ahrer K, Buchacher A, Iberer G, Jungbauer A. Thermodynamic stability and formation of aggregates of human immunoglobulin G characterised by differential scanning calorimetry and dynamic light scattering. J Biochem Biophys Methods 2006; 66:73 - 86; http://dx.doi.org/10.1016/j.jbbm.2005.12.003; PMID: 16458360
   PubMedGoogle Scholar
• Brezinschek HP, Foster SJ, Dörner T, Brezinschek RI, Lipsky PE. Pairing of variable heavy and variable kappa chains in individual naive and memory B cells. J Immunol 1998; 160:4762 - 7; PMID: 9590222
   PubMed Web of Science ®Google Scholar
• Luo J, Obmolova G, Huang A, Strake B, Teplyakov A, Malia T, et al. Coevolution of antibody stability and Vκ CDR-L3 canonical structure. J Mol Biol 2010; 402:708 - 19; http://dx.doi.org/10.1016/j.jmb.2010.08.009; PMID: 20727359
   PubMed Web of Science ®Google Scholar
• Walsh G, Jefferis R. Post-translational modifications in the context of therapeutic proteins. Nat Biotechnol 2006; 24:1241 - 52; http://dx.doi.org/10.1038/nbt1252; PMID: 17033665
   PubMed Web of Science ®Google Scholar
• Zheng Y, Tesar DB, Benincosa L, Birnböck H, Boswell CA, Bumbaca D, et al. Minipig as a potential translatable model for monoclonal antibody pharmacokinetics after intravenous and subcutaneous administration. MAbs 2012; 4:243 - 55; http://dx.doi.org/10.4161/mabs.4.2.19387; PMID: 22453096
   PubMed Web of Science ®Google Scholar
• Igawa T, Ishii S, Tachibana T, Maeda A, Higuchi Y, Shimaoka S, et al. Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization. Nat Biotechnol 2010; 28:1203 - 7; http://dx.doi.org/10.1038/nbt.1691; PMID: 20953198
   PubMed Web of Science ®Google Scholar
• Ravn U, Gueneau F, Baerlocher L, Osteras M, Desmurs M, Malinge P, et al. By-passing in vitro screening--next generation sequencing technologies applied to antibody display and in silico candidate selection. Nucleic Acids Res 2010; 38:e193; http://dx.doi.org/10.1093/nar/gkq789; PMID: 20846958
   PubMed Web of Science ®Google Scholar
• Venet S, Ravn U, Buatois V, Gueneau F, Calloud S, Kosco-Vilbois M, et al. Transferring the characteristics of naturally occurring and biased antibody repertoires to human antibody libraries by trapping CDRH3 sequences. PLoS One 2012; 7:e43471; http://dx.doi.org/10.1371/journal.pone.0043471; PMID: 22937053
   PubMedGoogle Scholar
• Kuroda D, Shirai H, Kobori M, Nakamura H. Systematic classification of CDR-L3 in antibodies: implications of the light chain subtypes and the VL-VH interface. Proteins 2009; 75:139 - 46; http://dx.doi.org/10.1002/prot.22230; PMID: 18798566
   PubMed Web of Science ®Google Scholar
• Retter I, Althaus HH, Münch R, Müller W. VBASE2, an integrative V gene database. Nucleic Acids Res 2005; 33:Database issue D671 - 4; http://dx.doi.org/10.1093/nar/gki088; PMID: 15608286
   PubMed Web of Science ®Google Scholar
• Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997; 25:3389 - 402; http://dx.doi.org/10.1093/nar/25.17.3389; PMID: 9254694
   PubMed Web of Science ®Google Scholar
• Honegger A, Plückthun A. Yet another numbering scheme for immunoglobulin variable domains: an automatic modeling and analysis tool. J Mol Biol 2001; 309:657 - 70; http://dx.doi.org/10.1006/jmbi.2001.4662; PMID: 11397087
   PubMed Web of Science ®Google Scholar
• Hieter PA, Maizel JV Jr., Leder P. Evolution of human immunoglobulin kappa J region genes. J Biol Chem 1982; 257:1516 - 22; PMID: 6276389
   PubMed Web of Science ®Google Scholar
• Kawasaki K, Minoshima S, Nakato E, Shibuya K, Shintani A, Schmeits JL, et al. One-megabase sequence analysis of the human immunoglobulin lambda gene locus. Genome Res 1997; 7:250 - 61; http://dx.doi.org/10.1101/gr.7.3.250; PMID: 9074928
   PubMed Web of Science ®Google Scholar
• Ravetch JV, Siebenlist U, Korsmeyer S, Waldmann T, Leder P. Structure of the human immunoglobulin mu locus: characterization of embryonic and rearranged J and D genes. Cell 1981; 27:583 - 91; http://dx.doi.org/10.1016/0092-8674(81)90400-1; PMID: 6101209
   PubMed Web of Science ®Google Scholar
• Stubenrauch K, Wessels U, Lenz H. Evaluation of an immunoassay for human-specific quantitation of therapeutic antibodies in serum samples from non-human primates. J Pharm Biomed Anal 2009; 49:1003 - 8; http://dx.doi.org/10.1016/j.jpba.2009.01.030; PMID: 19250787
   PubMed Web of Science ®Google Scholar
• Cho MS, Yee H, Chan S. Establishment of a human somatic hybrid cell line for recombinant protein production. J Biomed Sci 2002; 9:631 - 8; http://dx.doi.org/10.1007/BF02254991; PMID: 12432229
   PubMed Web of Science ®Google Scholar